Abstract
We discuss some of the issues emerging from a powerful legislative movement for preventive services over the past three years. During this time an increasing number of states passed, considered, or are currently developing breast cancer screening legislation. Most of these laws require some form of third party payment for mammography or establish breast cancer screening programs. The legislation varies markedly with regard to periodicity of examinations, ages covered, type and extent of third party coverage, dosage regulation, and radiographic equipment standards. This shows a need for common standards. Legislation provides an essential incentive for a public health response to a serious problem, but more than laws are needed. Health care providers and the general public need to be aware and take advantage of the coverage provided as a result of legislation. Moreover, public health officials need to be aware that such legislation may lead to a demand for services that exceeds present capacity to deliver them.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bang K. M., White J. E., Gause B. L., Leffall L. D., Jr Evaluation of recent trends in cancer mortality and incidence among blacks. Cancer. 1988 Mar 15;61(6):1255–1261. doi: 10.1002/1097-0142(19880315)61:6<1255::aid-cncr2820610634>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
- Centers for Disease Control (CDC) Provisional estimates from the National Health Interview Survey Supplement on Cancer Control--United States, January-March 1987. MMWR Morb Mortal Wkly Rep. 1988 Jul 15;37(27):417-20, 425. [PubMed] [Google Scholar]
- Chu K. C., Smart C. R., Tarone R. E. Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. J Natl Cancer Inst. 1988 Sep 21;80(14):1125–1132. doi: 10.1093/jnci/80.14.1125. [DOI] [PubMed] [Google Scholar]
- Dodd G. D. Is screening mammography routinely indicated for women between 40 and 50 years of age? An affirmative view. J Fam Pract. 1988 Sep;27(3):313–316. [PubMed] [Google Scholar]
- Eddy D. M., Hasselblad V., McGivney W., Hendee W. The value of mammography screening in women under age 50 years. JAMA. 1988 Mar 11;259(10):1512–1519. [PubMed] [Google Scholar]
- Feig S. A. Mammography screening: published guidelines and actual practice. Recent Results Cancer Res. 1987;105:78–84. doi: 10.1007/978-3-642-82964-2_12. [DOI] [PubMed] [Google Scholar]
- Howard J. Using mammography for cancer control: an unrealized potential. CA Cancer J Clin. 1987 Jan-Feb;37(1):33–48. doi: 10.3322/canjclin.37.1.33. [DOI] [PubMed] [Google Scholar]
- Huguley C. M., Jr Screening for breast cancer. J Med Assoc Ga. 1987 May;76(5):310–313. [PubMed] [Google Scholar]
- Martin J. E., Moskowitz M., Milbrath J. R. Breast cancer missed by mammography. AJR Am J Roentgenol. 1979 May;132(5):737–739. doi: 10.2214/ajr.132.5.737. [DOI] [PubMed] [Google Scholar]
- Shapiro S., Venet W., Strax P., Venet L., Roeser R. Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening. Natl Cancer Inst Monogr. 1985 May;67:65–74. [PubMed] [Google Scholar]
- Tabár L., Fagerberg C. J., Gad A., Baldetorp L., Holmberg L. H., Gröntoft O., Ljungquist U., Lundström B., Månson J. C., Eklund G. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet. 1985 Apr 13;1(8433):829–832. doi: 10.1016/s0140-6736(85)92204-4. [DOI] [PubMed] [Google Scholar]